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Abstract
Background: Fulminant hepatic failure (FHF) is rapidly fatal and liver transplant is the treatment
of choice. The condition is known for its heterogeneity of defining criteria, clinical presentation,
histologic spectrum and etiologic factors. The etiology of FHF varies widely, some of which includes
viral hepatitis, drug overdose and idiosyncratic drug reactions. The identification of the etiology of
FHF is critically important, because it influences the management. A histopathological classification
of FHF has not been reported earlier in the literature.
Methods: The current study was conducted retrospectively on 224 autopsies at a tertiary care
hospital in India. In all of these cases the liver was examined grossly and microscopically. Clinical
findings, serological data and immunohistochemical findings were correlated with the
morphological subtypes and a consensus morphological classification was formulated.
Results: Young females, especially those in the reproductive age group were most susceptible to
the disease. Hepatotropic viruses and drugs were the likely causes in most of the patients. Clinical
presentation is important, as delayed onset of encephalopathy or the subacute FHFs lead to
maximum mortality. After careful gross and microscopic examination the morphological findings of
FHF were divided into four distinct categories. Histologic typing can sometimes be misleading if
solely made on H & E slides without application of special stains.
Conclusion: Fulminant hepatic failure is a medical emergency, proper histological categorization
can help in deciding the treatment modalities.
Background
Fulminant hepatic failure (FHF) is a rapidly fatal condi-
tion when untreated. It is defined as the rapid develop-
ment of hepatocellular dysfunction and encephalopathy
in a person with no prior history of liver diseases [1]. Till
now, this condition was described in different ways by
various authors. In 1970, the term FHF was coined to
describe the onset of encephalopathy within 8 weeks of
the first evidence of jaundice without any pre-existing
liver disease [2]. In mid- 80s, French investigators divided
FHF into fulminant (encephalopathy within 2 weeks of
first appearance of jaundice) and subfulminant (encepha-
lopathy between 2 and 12 weeks) [3]. More recently, a fur-
ther classification into hyperacute (encephalopathy
within a week), acute (1 to 4 weeks) and subacute (5 to 26
weeks) FHF has been made [1,4]. These classifications are
based on clinical presentation of the patient, however his-
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topathologic spectrum of various subtypes of FHF has not
been classified yet [5,6].
The etiological factors of FHF are diverse in different geo-
graphical areas. In United States some investigators docu-
mented viral hepatitis as the leading cause of FHF (in one
eighth of total FHF cases) followed by drug toxicity and
idiosyncrasy, while other investigators found acetami-
nophen toxicity followed by non A non B non C hepatitis
as the leading cause of FHF [7-9]. Etiology also differs
between different age groups. Acute hepatitis A is the com-
monest cause in childhood, and has the best prognosis.
Hepatitis B, C, and D rarely cause fulminant hepatic fail-
ure in childhood while hepatitis E virus may be associated
with fulminant hepatic failure in children living in Indian
subcontinent [10,11]. Consideration of a possible less
common etiology, such as lymphoma or obesity is of con-
siderable clinical importance and may be needed to know
specific treatment measures [3,12].
Though there is no specific therapy for FHF, liver trans-
plantation is recommended for situations in which spon-
taneous recovery appears unlikely [13]. In literature it has
been documented that 40% of patients with FHF survives
without liver transplantation [14]. A careful and individu-
alistic approach is needed when treating an FHF patient. A
detailed clinical, etiologic and histopathologic correlation
is required. The current study on FHF therefore was con-
ducted retrospectively on autopsy material from a single
tertiary care hospital in North India, to identify the his-
topathologic spectrum and to determine the etiologies if
possible.
Methods
A retrospective study was performed on two hundred
twenty four autopsy cases of fulminant hepatic failure
since 1983 to 2002 (20 years) from our archive in Post-
graduate Institute of Medical Education and Research,
Chandigarh, India. We included these cases in our study
depending on the history of rapid development of hepa-
tocellular dysfunction in the form of jaundice, coagulop-
athy or presence of encephalopathy without prior history
of any liver disease. The cases of rapid development of
liver dysfunction with previous history of liver diseases
(e.g. cirrhosis, Wilson's disease or hemochromatosis) or
histologically proven hepatic necrosis without clinical evi-
dence of encephalopathy and in which no clinical diagno-
sis was made, were excluded from the study. A detailed
gross and microscopic examination was carried out. Gross
weight, architecture, capsular surface, cut surface and por-
tal vasculature of liver were studied carefully. At least three
Hematoxylin & Eosin stained slides along with special
stains like Gordon and Sweet's reticulin, Masson tri-
chrome, Shikata's orcein, Elastic Van Gieson, and Periodic
acid Schiff with and without diastase were studied in every
case. Immunohistochemistry for HBsAg and HBcAg was
carried out in all the cases. Serological data for viral and
autoimmune causes was retrieved. Wherever possible,
important antemortem drug history was recorded. The
four histological classes were defined as follows in our
study:
1.  Extensive multiacinar confluent hepatic necrosis
without regeneration – Characterized by diffuse transac-
inar loss of hepatocytes and replacement of hepatocytes
by acellular debri, fibrin and acute inflammatory infiltrate
with absence or occasional presence of macrophages. No
deposition of elastic fibers should be seen on special stain.
2. Multiacinar confluent hepatic necrosis with regener-
ation – Characterized by restricted parenchymal loss with
associated regeneration. The regenerative nodules showed
hepatocytes in double cords along with mild nucleomeg-
aly and cholestasis along with varying degree of cholangi-
olar regeneration. Macrophages were the predominant
population of inflammatory cells.
3. Bridging hepatic necrosis with regeneration – Charac-
terized by narrow band of necrosis extending from central
vein to portal tract or portal tract to portal tract. Number
of inflammatory cells and macrophages varied in this
type. Elastic fiber deposition may or may not be present.
4. Differential pathology – Characterized by admixture
of the above mentioned pathologies in any extent. For e.g.
confluent hepatic necrosis with or without regeneration in
one area and bridging hepatic necrosis with extensive
regeneration in the other areas.
Results
During the period of twenty years, since 1983 to 2002, a
total number of 10930 autopsies were performed;
amongst which 224 of FHF cases were selected based on
our inclusion criteria. Females were affected most, as a
total of 170 females with FHF were identified in our study
(75.8% of total number of FHF cases), which included 61
pregnant females, aged between 20 and 32 years. Forty-six
deceased were male, aged between 13 to 63 years and
eight were children below 12 years of age. In our study, 13
hyperacute and 48 acute forms of FHF were noted in preg-
nant females. In males and females not in reproductive
age group, 53 hyperacute, 104 acute and 6 subacute FHFs
were identified.
Pregnancy with FHF (61 cases)
A total 423 maternal deaths were recorded during this
period of time. Amongst which 95 deaths (22.4%) were
related to liver diseases. Of these, 61 deaths (64.2% of
liver related deaths) were due to fulminant hepatic failure.
The pregnant females who died of FHF presented betweenDiagnostic Pathology 2007, 2:27 http://www.diagnosticpathology.org/content/2/1/27
Page 3 of 8
(page number not for citation purposes)
28th to 38th weeks of their pregnancy. Of these, in eight
cases, hepatitis B virus infection was detected. In rest of
the cases, etiology was not made antemortem or postmor-
tem. Pregnancy with hepatitis E infection was not identi-
fied in the present study.
Clinically 13 of these cases had hyperacute presentation
and rest of them presented with acute form. A total of 46
autopsies in pregnant females demonstrated multiacinar
confluent hepatic necrosis without regeneration and in 12
cases multiacinar confluent hepatic necrosis with regener-
ation was noted.
FHF in other patients (163 cases)
There were Forty-six male patients, aged between 13 to 63
years, eight children below 12 years of age and 105
females not in reproductive age group. Most common age
groups affected were 13 and 29 years (61%), followed by
30–39 years (18%), 40–49 years (8%) and 50 years
onwards (13%). According to the clinical presentation, 53
cases were hyperacute (49 females and 14 males), 104
cases were acute and 6 cases were of subacute FHF. On his-
tologic examination, multifocal confluent hepatic necro-
sis without regeneration was the most common pattern
(47.8%), followed by multifocal confluent hepatic necro-
sis with regeneration (26.9%), bridging hepatic necrosis
(5.5%) and differential pathology in 30 cases (18.4%).
Etiologic Factors
In a total number of 224 cases, etiology could be deter-
mined in 49 cases, including 8 pregnant females with
HBsAg positivity. Etiologic factors in rest of the 41 cases
were as follows: HBsAg positivity in 18 cases (58%), HCV
Ab positivity in 4 cases (12%) and positive HEV serology
in 8 cases. One case did show combined HBsAg and HEV
positivity. None of the pregnant females in our study was
HEV serology positive. In six cases (3%), drug toxicity was
the offending agent and the drugs were INH (4 cases) and
acetaminophen (2 cases). Primary hepatic lymphoma was
identified in two cases and autoimmune hepatitis with
FHF and ischemic FHF were identified in one case each.
Rare causes like primary hepatic lymphoma, autoimmune
hepatitis or ischemia showed extensive multiacinar con-
fluent hepatic necrosis without regeneration. In rest of the
cases, etiology could not be confirmed or it was unknown.
Pathologic Findings
On gross examination, in massive confluent hepatic
necrosis, normal size and shape of liver remained undis-
turbed. While in subacute or massive hepatic failure with
formation of regenerative nodules - shrinkage of liver size,
wrinkled opaque capsular surface, dark discoloured soft
cut surface, concentration of the porto-venous radicals
close to one another and bile stained regenerative nodules
were identified. A bridging hepatic necrosis showed retic-
ulated cut surface where the viable part of the lobules were
seen separated by porto-portal or porto-central thin grey-
white lines of necrosis.
Histologic subclassification was as follows:
Extensive multiacinar confluent hepatic necrosis without 
regeneration – (Fig 1 &2)
There was transacinar extensive necrosis with maintained
liver architecture. Acute inflammatory infiltrate with only
occasional macrophages was identified.
This pattern was identified in 46 pregnant females and 78
other patients.
Multiacinar confluent hepatic necrosis with regeneration – 
(Fig 3, 4, 5, 6)
There was transacinar extensive hepatocyte necrosis with
formation of regenerative nodules at places. Due to for-
mation of regenerative nodules, the reticulin framework
of the necrotic area collapsed and formed 'passive septae'.
The necrotic zone showed presence of many macrophages
along with a mixed population of inflammatory cells.
Additional difficulty we faced was differentiation of this
group from cirrhosis grossly and on H & E sections,
because the passive septae formed by hepatocytes, resem-
bled fibrous bands. Shikata's orcein stain was helpful, as
it did not show any elastic fiber deposition in the passive
septae.
This pattern was identified in 12 Pregnant and in 44 other
patients
Bridging hepatic necrosis with regeneration – (Fig 7 &8)
In these cases a typical reticulated cut surface of liver was
identified. On microscopic examination narrow bands of
necrosis were seen present between portal tract to central
vein or another portal tract. Inflammatory cells were less
in comparison to the above mentioned types and com-
posed of variable number of macrophages.
In our study 2 pregnant females and 11 other deceased
were found to have this morphological spectrum.
Differential pathology – (Fig 9)
Admixture of the above mentioned pathologies in varying
extent, both grossly and microscopically, was identified.
We noted this morphological variation in 1 pregnant and
30 other males and females
In the hyperacute FHF the histological pattern was multi-
acinar confluent hepatic necrosis. Multiacinar confluent
necrosis, bridging hepatic necrosis and differential pathol-
ogy were noted in both acute and subacute FHF. Multiac-Diagnostic Pathology 2007, 2:27 http://www.diagnosticpathology.org/content/2/1/27
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inar confluent hepatic necrosis with regeneration,
bridging hepatic necrosis with regeneration and differen-
tial pathology were identified in subacute and chronic
FHF. In the present study, the earliest change of regenera-
tion was noted in three weeks.
Discussion
Fulminant hepatic failure is characterized by the rapid
onset of life threatening hepatic decompensation in
patients who have no previous history of liver disease [1].
First step of management is triaging patients according to
the presentation. Prognosis could be assumed from this
triage. According to the present study, the most common
presentation in FHF was acute (67.8%), followed by
hyperacute (29.4%) type. Subacute FHF was rarest. Our
findings were similar to a study from north India by Ach-
arya et al [15], who found acute form of FHF was most
prevalent. However these results do not correspond to the
observations from United Kingdom, France and Japan,
where the subacute type is the most common subtype
reported [15]. The differences of clinical presentation
between two geographical areas may be explained by the
difference of etiologic agents, host factors, environmental
factors and the nature of the study. Our study was a retro-
spective autopsy study, which may show different out-
come from those studied on living subjects. In different
published studies it has been shown that hyperacute liver
failure has better survival rate (27%, 5 year survival) than
acute (7%, 5 year survival) and subacute liver failures (0–
1%, 5 year survival) [5,16]. A large number of female
patients with FHF, in the present series, were pregnant and
all of them were in third trimester of pregnancy.
During epidemics of HEV infection, pregnant women
have been reported to have a high risk of developing acute
hepatitis as well as FHF compared with females not in
Gross photograph of a liver slice with massive confluent  hepatic necrosis Figure 1
Gross photograph of a liver slice with massive confluent 
hepatic necrosis. Normal liver size and shape are maintained.
Photomicrograph of liver section showing multiacinar conflu- ent hepatic necrosis Figure 2
Photomicrograph of liver section showing multiacinar conflu-
ent hepatic necrosis. Condensation of the central veins are 
seen with scant macrophages, H & E, × 40.
Gross photograph of liver with subacute hepatic failure  showing multiple regenerative nodules Figure 3
Gross photograph of liver with subacute hepatic failure 
showing multiple regenerative nodules. Size of the liver has 
reduced and the shape has altered.
Photomicrograph of liver showing varying sized regenerative  nodules surrounded by passive septae Figure 4
Photomicrograph of liver showing varying sized regenerative 
nodules surrounded by passive septae. This condition can be 
confused with cirrhosis by neophytes, H & E × 40.Diagnostic Pathology 2007, 2:27 http://www.diagnosticpathology.org/content/2/1/27
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reproductive age and males [17]. However this was not
substantiated in the current study; as we did not find any
case of HEV infection in these females. Explanation for
this difference is unclear. Based on the present findings it
can be postulated that pregnant females in their third tri-
mester with FHF have higher mortality than males with
FHF. On contrary Acharya et al [15] did not find preg-
nancy per se or the duration of the gestation as predictors
of the mortality in FHF.
The etiology of FHF is multifactorial, including viral hep-
atitis and drug toxicity [7], as can be seen in the present
study where viral hepatitis is the major cause of FHF
(79.5% of total known etiologies). Among the viruses,
hepatitis B was responsible for 53% of FHF. In other
series, hepatitis B was reported in around 50–60% cases of
FHF [18]. Overall, hepatitis B is reported as the most com-
mon cause of FHF worldwide [8]. Special virological fac-
tors may predispose to FHF in hepatitis B. These factors
could include a role of mutant strain, coinfection or
superinfection with the delta (hepatitis D) virus, and
chemotherapy related reactivation of hepatitis B virus
[19]. However observations of studies from Indian sub-
continent incriminate non-A, non-B virus as the major
cause of FHF in this country [15,20]. Since in the current
study etiology could be determined in only 49 cases,
therefore in rest of the cases possibility of seronegative
hepatitis can not be completely ruled out. Only one case
in this series was positive for Hepatitis A serology. In liter-
ature, one case of FHF with proven hepatitis A has been
Silver impregnation technique highlightes the compressed  hepatic reticulin archietecture, Gordon and Sweet's silver  impregnation technique × 40 Figure 5
Silver impregnation technique highlightes the compressed 
hepatic reticulin archietecture, Gordon and Sweet's silver 
impregnation technique × 40.
Shikata's orcein stain showed absence of elastic fibres in the  passive septae, Shikata's orcein silver stain × 100 Figure 6
Shikata's orcein stain showed absence of elastic fibres in the 
passive septae, Shikata's orcein silver stain × 100.
Gross photograph showing reticulated cut surface; liver cap- sule is opaque and corrugated Figure 7
Gross photograph showing reticulated cut surface; liver cap-
sule is opaque and corrugated.
Photomicrograph of liver showing thin necrotic bands con- necting portal tracts to portal tracts and central veins; inflam- matory cells are scanty without collagen deposition, Masson  trichrome × 40 Figure 8
Photomicrograph of liver showing thin necrotic bands con-
necting portal tracts to portal tracts and central veins; inflam-
matory cells are scanty without collagen deposition, Masson 
trichrome × 40.Diagnostic Pathology 2007, 2:27 http://www.diagnosticpathology.org/content/2/1/27
Page 6 of 8
(page number not for citation purposes)
documented previously from India [21]. Most studies
reviewed indicate that hepatitis C virus does not result in
a fulminant course [18], whilst 8.1 % of our FHF cases
showed positive hepatitis C serology. Two reports from
France and Japan [22], noted coinfection of hepatitis C
and hepatitis B virus in upto 50% patients with fulminant
hepatic failure but it was not observed in our cases.
Regarding hepatitis E, the virus usually shows a fulminant
course in pregnant women in Indian subcontinent, while
it plays a minor role in the west and is mainly reported in
travelers to endemic areas [11,23]. HEV in the present
study was the second most common cause (16.3%) for
FHF after hepatitis B (53%) infection in males and
females of nonreproductive age group. Most cases of drug
related FHF resulted from acetaminophen overdose. In
fact, acetaminophen is the most common cause of FHF in
United States [9,14]. This drug is directly hepatotoxic and
predictably produces hepatocellular necrosis with over-
dose [24]. Numerous other drugs including halothane,
Isoniazid, Sodium Valproate, Carbamazepine, and
Phenytoin have been implicated as etiological factors in
FHF [3,10]. In the present study, acetaminophen (two
cases) and Isoniazid (four cases) were the two offender
drugs responsible for FHF. Drugs were found next to
viruses as etiological factors.
In all reported series of FHF, in a sizable number of cases
(10% to 45% in the west) no etiology can be demon-
strated [25]. In the present study, out of 224 cases studied,
in only 49 patients (21.8%) etiologies could be con-
firmed. In rest of the cases, etiology could not be deter-
mined or was unknown. Our study is a retrospective study
and the unavailability of the serological facilities in the
past may have contributed for the same.
A group of rare etiologies are worth considering because
they may be curable with specific therapies. One of such
factors is obesity. Since our study is retrospective and BMI
of patients were not documented, we could not evaluate
obesity as an etiologic factor in our patients. Canbay et al
did a retrospective study on 34 patients of acute on
chronic liver failure and acute liver failure, and concluded
that elevated BMI coincided with a higher rate of acute on
chronic liver failure rather than with acute liver failure
[12].
Other such factors are hepatic lymphoma (Fig 10),
autoimmune hepatitis and ischemic hepatic failure.
Recently Mudawi and Yousif [26] have reported associa-
tion of FHF with non Hodgkin's lymphoma. Interestingly,
in NHL, chemotherapy induced FHF has also been
described in the literature, however in our case no such
history was detected. FHF traditionally is associated with
up to 90% mortality. Earlier recognition of the causative
agents and improved management has led to an improved
survival. However unfortunately, a considerable number
of patients succumb to this disease [27].
The gross findings of FHF are not always informative
enough for proper morphological classification or in
determining the cause. However, the overall size, weight
of the liver and features on cut surface are important to
estimate the onset and the severity of the event. Liver size
usually remains normal in hyperacute and acute FHF and
massive hepatic necrosis without regeneration. On the
contrary, the liver size shrinks when the sequence of
events is relatively slower to start with or when associated
with early events of regeneration. Clinically subacute liver
failure and grossly shrunken liver size have been identi-
fied as a most frequent association with death in FHF
[5,10,28].
The heterogeneity of morphological findings in FHF have
been mentioned in previous studies by Hanau et al [5]
Photomicrograph showing diffuse destruction of the liver  archietecture by infiltrating malignant lymphoid cells, H & E ×  40 Figure 10
Photomicrograph showing diffuse destruction of the liver 
archietecture by infiltrating malignant lymphoid cells, H & E × 
40.
Gross photograph of liver with differential pathology Figure 9
Gross photograph of liver with differential pathology. Central 
area of confluent hepatic necrosis flanked by areas with retic-
ulated cut surface.Diagnostic Pathology 2007, 2:27 http://www.diagnosticpathology.org/content/2/1/27
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and Shimizu et al [6], but not classified yet. Pathologists
and hepatologists working in this field should be aware of
the various morphological spectrums that can be seen in
this condition, because morphological categorization can
give an idea about possible outcome. An urgent percuta-
neous needle biopsy in FHF patients can deliver impor-
tant information. Main histological subgroups identified
in these 224 cases are: extensive multiacinar confluent
hepatic necrosis without regeneration (126 cases), multi-
acinar confluent hepatic necrosis with regeneration (56
cases), bridging hepatic necrosis with regeneration (11
cases) and differential pathology (combination of other
categories) (31 cases). The classification was based on the
extent of the acinar hepatocyte destruction, pattern of
necrosis, type of inflammatory cell infiltration, extent of
deposition of elastic fibers (with Shikata's orcein) and
presence of features of regeneration [5,28-30].
However diagnostic pitfalls in FHF should always be kept
in mind to avoid determination of erroneous categoriza-
tion. One of such problems is to differentiate the multiac-
inar hepatic necrosis with regenerative nodule from
cirrhosis grossly or on microscopy. The passive septae
formed by collapsed reticulin framework due to necrosis
can mimic fibrous bands of cirrhosis. These collapsed
bands are formed passively and not by active laying down
of collagen fibers. Shikata's orcein stain should always be
used routinely. Negative staining in such a condition
determines passive septae formation. Determination of
etiology is very difficult when liver has undergone necro-
sis. Immunohistochemistry in this condition can lead to
erroneous diagnosis due to extensive background stain-
ing. This limitation was realized by other authors also
[6,28,31]. That is why in a large percentage of FHF cases,
etiology could not be ascertained. Moreover, serology
facility was limited in past, hence we could not rule out
the true idiopathic cases. It has been previously described
that death rate is maximum in subacute hepatic failure
[6,15]. From our morphological study it was noted that
subacute FHF had the maximum number of macrophages
within the necrotic zone, though it is not proved from this
study, it can be assumed that the cytokines released by the
accumulating macrophages produce systemic inflamma-
tory response and multiorgan failure. Thus, we again
emphasize the importance of proper histological classifi-
cation, if it can be achieved on premortem needle biop-
sies. This information may help the surgeons to take
urgent decision about the necessity of liver transplant in
patients of subacute FHF.
Discussion of the treatment part is far from the scope of
this study, however we feel to conclude the discussion
with the emphasis on proper selection of patients for liver
transplant for better outcome. On average 50% of FHF
patients undergo liver transplant as liver transplantation
is the most promising treatment.
Conclusion
To summarize the important facts about FHF we could
gather from this study, are:
￿ Morphologically FHFs may be categorized into four
classes on premortem needle biopsies and transplant deci-
sion may be taken accordingly, as transplant is most
needed and successful in subacute FHF.
￿ Submassive hepatic necrosis with nodular regeneration
should not be confused with cirrhosis.
￿ Females, especially those in the reproductive age group
are at risk, as 123 females including pregnant ones, of a
total of 224 cases, died of FHF (54.91%). Pregnant
females are affected most in third trimester.
￿ Pregnancy with FHF imparts a potential threat for mater-
nal death, as 61 of 95 (64.2%) liver related maternal
deaths were due to FHF.
￿ Most common antemortem-presentation was acute, fol-
lowed by hyperacute and subacute FHFs. It can be
assumed retrospectively that patient who presented with
encephalopathy after 7 days of onset of jaundice or coag-
ulopathy, die most frequently.
￿ Autoimmune hepatitis, primary hepatic lymphoma and
ischemic hepatocyte necrosis can present with FHF.
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